Diabetic ketoacidosis following development of de novo diabetes in renal transplant recipient associated with tacrolimus
dc.contributor.buuauthor | Ersoy, Alparslan | |
dc.contributor.buuauthor | Ersoy, Canan | |
dc.contributor.buuauthor | Tekçe, Hikmet | |
dc.contributor.buuauthor | Yavaşçaoǧlu, İsmet | |
dc.contributor.buuauthor | Dilek, Kamil | |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Nefroloji Bilim Dalı. | tr_TR |
dc.contributor.orcid | 0000-0002-0710-0923 | tr_TR |
dc.contributor.researcherid | AAH-5054-2021 | tr_TR |
dc.contributor.scopusid | 35612977100 | tr_TR |
dc.contributor.scopusid | 6701485882 | tr_TR |
dc.contributor.scopusid | 16687238400 | tr_TR |
dc.contributor.scopusid | 6603612497 | tr_TR |
dc.contributor.scopusid | 56005080200 | tr_TR |
dc.date.accessioned | 2022-05-05T10:45:46Z | |
dc.date.available | 2022-05-05T10:45:46Z | |
dc.date.issued | 2004-06 | |
dc.description.abstract | Although drugs used in renal transplant recipients such as steroids, cyclosporine, and particularly, tacrolimus have diabetogenic potential, diabetic ketoacidosis is uncommon. There are few data concerning the long-term follow-up of these patients. Diabetic ketoacidosis occurred in a renal transplant recipient following de novo development associated with tacrolimus. | en_US |
dc.identifier.citation | Ersoy, A. vd. (2004). “Diabetic ketoacidosis following development of de novo diabetes in renal transplant recipient associated with tacrolimus”. Transplantation Proceedings, 36(5), 1407-1410. | en_US |
dc.identifier.endpage | 1410 | tr_TR |
dc.identifier.issn | 0041-1345 | |
dc.identifier.issue | 5 | tr_TR |
dc.identifier.pubmed | 15251345 | tr_TR |
dc.identifier.scopus | 2-s2.0-3142538604 | tr_TR |
dc.identifier.startpage | 1407 | tr_TR |
dc.identifier.uri | https://doi.org/10.1016/j.transproceed.2004.04.080 | |
dc.identifier.uri | https://www.sciencedirect.com/science/article/pii/S0041134504005123 | |
dc.identifier.uri | http://hdl.handle.net/11452/26288 | |
dc.identifier.volume | 36 | tr_TR |
dc.identifier.wos | 000222713000049 | |
dc.indexed.pubmed | PubMed | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.wos | SCIE | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier Science | en_US |
dc.relation.journal | Transplantation Proceedings | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Immunology | en_US |
dc.subject | Surgery | en_US |
dc.subject | Transplantation | en_US |
dc.subject | Kidney-transplantation | en_US |
dc.subject | Allograft recipients | en_US |
dc.subject | Patient survival | en_US |
dc.subject | Randomized-trial | en_US |
dc.subject | Risk-factors | en_US |
dc.subject | Mellitus | en_US |
dc.subject | Immunosuppression | en_US |
dc.subject | Cyclosporine | en_US |
dc.subject | Insulin | en_US |
dc.subject | FK506 | en_US |
dc.subject.emtree | Adult | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Case report | en_US |
dc.subject.emtree | Clinical feature | en_US |
dc.subject.emtree | Diabetes mellitus | en_US |
dc.subject.emtree | Diabetic ketoacidosis | en_US |
dc.subject.emtree | Disease course | en_US |
dc.subject.emtree | Drug dose reduction | en_US |
dc.subject.emtree | Female | en_US |
dc.subject.emtree | Follow up | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Immunosuppressive treatment | en_US |
dc.subject.emtree | Kidney graft rejection | en_US |
dc.subject.emtree | Kidney transplantation | en_US |
dc.subject.emtree | Laboratory test | en_US |
dc.subject.emtree | Priority journal | en_US |
dc.subject.emtree | Treatment failure | en_US |
dc.subject.emtree | Treatment outcome | en_US |
dc.subject.emtree | Bicarbonate | en_US |
dc.subject.emtree | Infusion fluid | en_US |
dc.subject.emtree | Insulin | en_US |
dc.subject.emtree | Sodium chloride | en_US |
dc.subject.emtree | Tacrolimus | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Diabetic ketoacidosis | en_US |
dc.subject.mesh | Drug therapy, combination | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Immunosuppressive agents | en_US |
dc.subject.mesh | Kidney transplantation | en_US |
dc.subject.mesh | Peritoneal dialysis, continuous ambulatory | en_US |
dc.subject.mesh | Postoperative complications | en_US |
dc.subject.mesh | Tacrolimus | en_US |
dc.subject.mesh | Treatment outcome | en_US |
dc.subject.scopus | Kidney Transplantation; Diabetes Mellitus; Transplant Recipients | en_US |
dc.subject.wos | Immunology | en_US |
dc.subject.wos | Surgery | en_US |
dc.subject.wos | Transplantation | en_US |
dc.title | Diabetic ketoacidosis following development of de novo diabetes in renal transplant recipient associated with tacrolimus | en_US |
dc.type | Article |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: